# Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer Patients

> **NCT02946671** · PHASE1 · COMPLETED · sponsor: **Osaka University** · enrollment: 16 (actual)

## Conditions studied

- Gastric Cancer
- Esophageal Cancer
- Lung Cancer
- Renal Cancer
- Oral Cancer

## Interventions

- **BIOLOGICAL:** Mogamulizumab
- **BIOLOGICAL:** Nivolumab

## Key facts

- **NCT ID:** NCT02946671
- **Lead sponsor:** Osaka University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2020-03
- **Final completion:** 2020-03
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2020-03-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02946671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02946671, "Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02946671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*